Director, Finance

Alnylam Pharmaceuticals · Tokyo

Apply on the company website

Director, Finance – Japan (Head of Finance, Japan)

Overview

Japan is one of Alnylam’s most important and fastest-developing markets worldwide, at a stage of sustained growth and expanding strategic importance. The Director, Finance – Japan is the most senior finance leader in the affiliate and serves as the Head of Finance for the entire Japan operation, as a core member of the Japan Leadership Team (JLT) and a trusted business partner to the Country General Manager.

This leader owns the full breadth of the finance agenda in Japan – financial planning and analysis, accounting and statutory compliance, finance operations, and strategic sourcing – delivered through a capable local team of three direct reports. The role is the single point of financial leadership and accountability for the affiliate, supporting every expertise area operating in Japan, and represents Japan within the International and Global Finance organizations.

This position is hybrid onsite and remote working and will be primarily located at Alnylam Japan office in Tokyo.

Reports to: Head of International Commercial Finance

Career track / level: Managerial – Director (M5)

Direct reports: 3 FTEs – Accounting, Finance Operations, Strategic Sourcing

Key Responsibilities

Finance leadership and business partnering

Financial planning and analysis

Accounting, compliance, and controls

Finance operations and strategic sourcing

Cross-functional and cross-entity support

Team leadership

Qualifications

What Makes This Role Distinctive

About Alnylam

Alnylam (Nasdaq: ALNY) is a leading global biopharmaceutical company and the pioneer of the RNA interference (RNAi) revolution. For more than two decades, the company has advanced the Nobel Prize-winning science of RNAi to develop transformative therapies with the potential to prevent, halt, or reverse disease. Alnylam today has six approved medicines available in more than 70 countries, together with a rapidly expanding pipeline, and is executing its Alnylam 2030 strategy to accelerate innovation and scale its impact on human health.

In Japan, Alnylam Japan K.K. was established in 2018 and is headquartered in Marunouchi, Tokyo. The affiliate has grown into one of the company’s most important international operations, with multiple RNAi therapeutics approved and marketed for rare and serious diseases, including ATTR amyloidosis, acute hepatic porphyria, and a footprint that continues to expand alongside new indications.

Our people-first culture is guided by our core values – Fiercely Innovative, Open Culture, Purposeful Urgency, Passion for Excellence, and Commitment to People – and these values shape how we work and the business decisions we make. Alnylam is consistently recognized as a top employer in the life sciences industry – a reflection of a high-performing organization where excellence and accountability go hand in hand with our commitment to people.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.

More jobs at Alnylam Pharmaceuticals · Finance & Accounting jobs in Tokyo